ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thermo Fisher Scientific will acquire the Swedish proteomics specialist Olink for $3.1 billion. Drawing on a library of 5,300 validated protein biomarkers, Olink has developed a high-throughput analysis platform for protein sequencing. The company has operations in the US and Asia as well as Europe. Olink’s proteomics capabilities will complement Thermo Fisher’s mass spectrometry and other assets in life sciences technology, Thermo Fisher CEO Marc N. Casper says in a press release announcing the deal. The sale is likely to be completed by mid-2024.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter